XEPTAGEN is situated at the VEGA Science Park in Venice, Italy. The center is dedicated to the development of nano-biotechnology applications in molecular oncology and R&D processes for drug discovery. Strong investments have equipped the facility with state of the art technology and the most up-to-date equipment for high-throughput protein screening and for developing latest generation diagnostic devices and therapeutics in oncology.
XEPTAGEN shares a strong expertise in molecular oncology, Combinatorial Proteomic®, combinatorial chemistry, biochemistry and molecular immunology. In addition, extensive experience is available on production, purification and characterization of monoclonal and polyclonal antibodies.

Research Capabilities

  • Peptide synthesis and purification
  • Recombinant protein production and purification
  • Monoclonal antibody production and purification
  • Polyclonal antibody production and purification
  • ELISA: Assay development
  • Assay of gene expression
  • High-throughput gene mutation scanning
  • High-throughput polymorphism screening
  • Biomarker discovery
  • Combinatorial Chemistry
  • Proteomics
  • Combinatorial proteomic
  • Molecular toxicology